Benjamin Besse
Top Publications Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer (2013) – 3,435 citations Sotorasib for Lung Cancers with KRAS p.G12C Mutation (2021) – 1,887 citations Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials (2019) – 1,805 citations Integrative genome analyses identify key somatic ... <a title="Benjamin Besse" class="read-more" href="https://journalsworld.com/researchers/benjamin-besse/" aria-label="Read more about Benjamin Besse">Read more</a>
Read biography ↓Biography, research & contributions
Top Publications
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer (2013) - 3,435 citations
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation (2021) - 1,887 citations
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials (2019) - 1,805 citations
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer (2012) - 1,435 citations
- Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry (2019) - 1,398 citations
At a glance
- Full name
- Benjamin Besse
- ORCID
- 0000-0001-5090-8189
- OpenAlex ID
- https://openalex.org/A5023794502
Research interests
- Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Cancer Genomics and Diagnostics
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer ↗2013 · New England Journal of Medicine3,435OpenAlex citations
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation ↗2021 · New England Journal of Medicine1,887OpenAlex citations
- 1,805OpenAlex citations
- 1,435OpenAlex citations
- 1,398OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer ↗2013 · New England Journal of Medicine
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation ↗2021 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 23:21:59
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.